All Children Deserve to Be Safe, Mothers Too: Evidence and Rationale Supporting CGM Use in Gestational Diabetes Within the Medicaid Population

Carol J. Levy, Rodolfo J. Galindo, Christopher G. Parkin, Jacob Gillis, Nicholas B. Argento

Research output: Contribution to journalComment/debate

Abstract

Gestational diabetes mellitus (GDM) is a common metabolic disease of pregnancy that threatens the health of several million women and their offspring. The highest prevalence of GDM is seen in women of low socioeconomic status. Women with GDM are at increased risk of adverse maternal outcomes, including increased rates of Cesarean section delivery, preeclampsia, perineal tears, and postpartum hemorrhage. However, of even greater concern is the increased risk to the fetus and long-term health of the child due to elevated glycemia during pregnancy. Although the use of continuous glucose monitoring (CGM) has been shown to reduce the incidence of maternal and fetal complications in pregnant women with type 1 diabetes and type 2 diabetes, most state Medicaid programs do not cover CGM for women with GDM. This article reviews current statistics relevant to the incidence and costs of GDM among Medicaid beneficiaries, summarizes key findings from pregnancy studies using CGM, and presents a rationale for expanding and standardizing CGM coverage for GDM within state Medicaid populations.

Original languageEnglish
JournalJournal of diabetes science and technology
DOIs
StateAccepted/In press - 2023

Keywords

  • CGM
  • Centers for Medicare & Medicaid Services
  • GDM
  • Medicaid
  • continuous glucose monitoring
  • gestational diabetes
  • insurance coverage
  • type 1 diabetes
  • type 2 diabetes

Fingerprint

Dive into the research topics of 'All Children Deserve to Be Safe, Mothers Too: Evidence and Rationale Supporting CGM Use in Gestational Diabetes Within the Medicaid Population'. Together they form a unique fingerprint.

Cite this